Emerging Invasive Fungal Infections in Critically Ill Patients (EIFI)
Status
Conditions
Details and patient eligibility
About
Rationale: Beside Candida and Aspergillus, emerging invasive fungal infections (EIFIs) are increasing in intensive care setting and are associated with high morbidity and mortality. However, data are scarce, particularly in ICU settings and for EIFIs other than mucormycosis.
Objectives: to describe epidemiological trends and clinical features of EIFIs in intensive care units (ICU) and to assess their outcome.
Methods: All records of adult patients diagnosed with an EIFI in a medical ICU between 2006 and 2019 were analyzed retrospectively. In-ICU mortality was assessed, then factors associated with mortality were identified. Survival at day-90 was calculated by the Kaplan-Meier method.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Adults (≥ 18 years old) with at least 1 positive culture for molds other than candida and aspergillosis
Exclusion criteria
- Age < 18, pregnancy
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal